Processa Pharmaceuticals presents at MedInvest Oncology Conference on Dec 5, 2023

Processa Pharmaceuticals, Inc.

Dr. David Young, President R&D, presents virtually at MedInvest Oncology Conference on Dec 5, 2023.
Presentation titled 'Next Generation Chemotherapy: Improved Treatment for More Patients' at 1:35 PM PT/4:35 PM ET.
CEO George Ng attends in person and is available for Q&A and one-on-one meetings.
Presentation uploaded to investor portal and made available on Processa's website.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.